Quentin Blackford

Quentin Blackford is currently the President & CEO at iRhythm Technologies. Prior to this, they were a Member of the Board of Directors at axogen from May 2019 to March 2022. Before that, they were the Chief Operating Officer at Dexcom from September 2017 to October 2021.

From February 2009 to September 2017, Quentin was the EVP–CFO, Head of Strategy & Corporate Integrity at NuVasive. In this role, they were responsible for leading global finance and evaluating M&A opportunities. Quentin also oversaw the culture, growth, change, and spending as the Corporate Controller. During their time at NuVasive, they took the share price from the 40’s through a transition into the 80’s by refocusing from revenue growth to earnings growth with a higher valuation. Quentin also implemented productivity metrics throughout most of the organization and led successful acquisitions of Biotronic Neuro-Network, SafeRay technologies, and Mega Surgical (the company's Brazilian distributor).

Quentin has a proven track record as an analytical and value-focused change agent. Quentin has successfully transitioned companies through periods of unprecedented growth while ensuring continuous investor returns.

Quentin Blackford has a Bachelor of Science in Business Administration and Management from Grace College & Seminary as well as a Bachelor of Science in Accounting. Quentin is also certified as a Certified Public Accountant from the Indiana CPA Society.

Sandrine Moirez - International General Manager, Douglas Devine - CFO & COO, and Patrick M. Murphy - Chief Legal Officer report to Quentin Blackford.